2

This is a standard post format with preview Picture

/0 Comments/in , /by

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, venenatis vitae, justo. Nullam dictum felis eu pede mollis pretium. Integer tincidunt. Cras dapibus. Vivamus elementum semper nisi.

Read more →

0 Comments

Seattle Times: New Prescription Monitoring Draws Complaints

/4 Comments/in /by

Since October, pharmacies around the state have been sending information into a giant computer database, detailing every prescription they’ve dispensed for controlled substances. That means every pain pill and patch, every anti-anxiety medication, every sleeping pill — listed by the patient’s name.

Beginning Wednesday, pharmacists, doctors and other prescribers will be able to see all such drugs a patient is getting anywhere in the state, even if the person pays with cash.

The state’s new Prescription Monitoring Program (PMP) will list all the doctors prescribing the pills and will even spit out a color-coded map showing every place the patient got drugs.

Read More: seattletimes.nwsource.com/html/localnews/2017147316_prescriptions04m

4 Comments

The New York Times: The High Cost of Failing Artificial Hips

/3 Comments/in /by

The most widespread medical implant failure in decades — involving thousands of all-metal artificial hips that need to be replaced prematurely — has entered the money phase.

Medical and legal experts estimate the hip failures may cost taxpayers, insurers, employers and others billions of dollars in coming years, contributing to the soaring cost of health care. The financial fallout is expected to be unusually large and complex because the episode involves a class of products, not a single device or just one company.

The case of Thomas Dougherty represents one particularly costly example. He spent five months this year without a left hip, largely stuck on a recliner watching his medical bills soar.

Read More: http://www.nytimes.com/2011/12/28/business/the-high-cost-of-failing-artificial-hips.html

3 Comments

Rheumatology News: FDA Advises Caution When IV Methotrexate-PPI Used Together

/2 Comments/in /by

Administration of a proton pump inhibitor with intravenous methotrexate may result in elevated serum levels of methotrexate, with toxic consequences, according to a statement issued on Dec. 21 by the Food and Drug Administration.

Case reports and published pharmacokinetic studies “suggest” that concomitant use of proton pump inhibitors (PPIs) with methotrexate, primarily high dose methotrexate, “may elevate and prolong serum levels of methotrexate and/or its metabolite hydroxymethotrexate, possibly leading to methotrexate toxicities,” the statement says.

Read More: http://www.rheumatologynews.com/single-view/fda-advises-caution-when-iv-methotrexate-ppi-used-together/2dc8f226f5.html

2 Comments

About.com: Dating Advice For People With Arthritis

/2 Comments/in /by

Shed Your Worries and Focus on What’s Most Important

Dating can be an intense experience under the best of circumstances. If you have physical limitations from a medical condition, such as arthritis, you may be apprehensive about the dating process, but relationships and dating are part of life. With the right perspective and approach, dating can enhance your life.

Read More: http://arthritis.about.com/od/sex/a/Dating-Advice-For-People-With-Arthritis

2 Comments